InsideTrading SEC Form 4 insider trades

Stocks

ELUT ELUTIA INC.

Healthcare · Biological Products, (No Diagnostic Substances) · Market cap: $36.3M

–

Bought and sold by quarter, last 5 years

Open-market purchases and sales by this company's insiders, in dollars, last 5 years

Quarterly insider purchases and sales 2022-Q1: bought $0, sold $0 2022-Q2: bought $1.2K, sold $0 2022-Q3: bought $0, sold $0 2022-Q4: bought $4.0M, sold $0 2023-Q1: bought $206.8K, sold $1.2K 2023-Q2: bought $0, sold $0 2023-Q3: bought $0, sold $0 2023-Q4: bought $0, sold $0 2024-Q1: bought $0, sold $0 2024-Q2: bought $0, sold $0 2024-Q3: bought $0, sold $0 2024-Q4: bought $0, sold $0 2025-Q1: bought $1.0M, sold $0 2025-Q2: bought $0, sold $0 2025-Q3: bought $0, sold $0 2025-Q4: bought $109.9K, sold $0 2026-Q1: bought $126.8K, sold $0 2026-Q2: bought $0, sold $0 2026-Q3: bought $0, sold $0 2026-Q4: bought $0, sold $0
Bought, above the line (largest quarter $4.0M) Sold, below the line (largest quarter $1.2K)
Quarterly insider purchases and sales
QuarterBoughtSold
2022-Q1$0$0
2022-Q2$1.2K$0
2022-Q3$0$0
2022-Q4$4.0M$0
2023-Q1$206.8K$1.2K
2023-Q2$0$0
2023-Q3$0$0
2023-Q4$0$0
2024-Q1$0$0
2024-Q2$0$0
2024-Q3$0$0
2024-Q4$0$0
2025-Q1$1.0M$0
2025-Q2$0$0
2025-Q3$0$0
2025-Q4$109.9K$0
2026-Q1$126.8K$0
2026-Q2$0$0
2026-Q3$0$0
2026-Q4$0$0

Insider activity

Download CSV Up to 5,000 rows
Bought$7.3M29 buy days
Sold$1.2K1 sell day
Net insider flow+$7.3Mnet buying · 5 years
Latest trade2026-01-30RAKIN KEVIN
Insider trades for this stock
Date Side Insider Role Shares Avg price Value Trades
2026-01-30 Buy RAKIN KEVIN Director 70,000 $1.06 $74.2K 1
2026-01-30 Buy NEELS GUIDO J Director 20,000 $1.04 $20.8K 1
2026-01-29 Buy NEELS GUIDO J Director 15,000 $1.06 $15.9K 1
2026-01-28 Buy NEELS GUIDO J Director 15,000 $1.06 $15.9K 1
2025-12-17 Buy Ferguson Matthew CFO 60,000 $0.53 $31.8K 1
2025-12-17 Buy RAKIN KEVIN Director 50,000 $0.52 $26.0K 1
2025-12-17 Buy Makes Brigid Director 25,000 $0.52 $13.0K 1
2025-12-17 Buy Colpman David Director 12,500 $0.51 $6.4K 1
2025-12-17 Buy Mills C Randal CEO 3,000 $0.51 $1.5K 1
2025-12-02 Buy Ferguson Matthew CFO 5,500 $0.67 $3.7K 1
2025-12-01 Buy Ferguson Matthew CFO 4,500 $0.65 $2.9K 1
2025-11-24 Buy Mills C Randal CEO 5,000 $0.60 $3.0K 1
2025-11-17 Buy Colpman David Director 15,500 $0.74 $11.5K 1
2025-11-13 Buy Mills C Randal CEO 13,500 $0.75 $10.1K 3
2025-02-03 Buy HighCape Capital, L.P. Director 420,000 $2.50 $1.0M 1
2023-03-27 Buy Strobeck Matthew Other 10,000 $1.59 $15.9K 1
2023-03-24 Buy Strobeck Matthew Other 20,000 $1.35 $27.0K 2
2023-03-23 Buy Strobeck Matthew Other 110,000 $1.49 $163.9K 2
2023-03-09 Sell Englese Thomas Other C-suite 289 $4.30 $1.2K 1
2022-12-15 Buy Colpman David Director 3,098 $3.90 $12.1K 1
2022-12-09 Buy Makes Brigid Director 2,000 $3.65 $7.3K 1
2022-12-08 Buy Strobeck Matthew 10% owner 13,061 $3.79 $49.5K 2
2022-12-07 Buy Strobeck Matthew 10% owner 44,000 $3.58 $157.5K 2
2022-12-05 Buy RAKIN KEVIN Director 735,000 $4.75 $3.5M 1
2022-12-05 Buy Ferguson Matthew CFO 22,000 $4.65 $102.2K 2
2022-12-02 Buy Ferguson Matthew CFO 6,000 $4.03 $24.2K 1
2022-12-01 Buy Strobeck Matthew 10% owner 40,000 $4.75 $190.0K 1
2022-05-11 Buy Strobeck Matthew 10% owner 200 $5.96 $1.2K 1
2021-12-14 Buy Englese Thomas Other C-suite 4,580 $6.10 $27.9K 1
2021-12-08 Buy RAKIN KEVIN Director 412,735 $4.24 $1.7M 2

Who the insiders are, last 5 years

Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.

Insiders of this company with their purchases and sales
Insider Role Bought Sold Last trade
RAKIN KEVIN Director $6.4M $0 2026-01-30
Strobeck Matthew Other $605.0K $0 2023-03-27
Ferguson Matthew CFO $164.8K $0 2025-12-17
NEELS GUIDO J Director $52.6K $0 2026-01-30
Colpman David Director $29.9K $0 2025-12-17
Englese Thomas Other C-suite $27.9K $1.2K 2023-03-09
Makes Brigid Director $20.3K $0 2025-12-17
Mills C Randal CEO $14.6K $0 2025-12-17

Past buying clusters

A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.

Buying clusters at this company, newest first, with the return against the benchmark that followed
Window Insiders Total Score 21 days vs benchmark63 days vs benchmark126 days vs benchmark Status
2025-11-13 → 2025-12-17 5 $109.9K 54 -13.6% (-12.3% raw)+56.6% (+55.7% raw)+33.7% (+42.7% raw) closed
2022-12-01 → 2022-12-15 5 $4.0M 57 +4.0% (+1.6% raw)+12.9% (+9.9% raw)-47.5% (-38.7% raw) closed

Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.